Status:
RECRUITING
The Effect of Perioperative Heated Sock Application on Hypothermia and Vital Signs in Bladder Tumor Surgery
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Bladder Tumor
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the effect of perioperative use of heated socks on the prevention of hypothermia and its impact on vital signs in patients undergoing bladder tumor surgery. It is ...
Detailed Description
Bladder cancer accounts for 2-3% of all malignant tumors and constitutes 6-8% of all malignancies in men and 2-3% in women. Globally, it ranks as the seventh most common cancer in men and the seventee...
Eligibility Criteria
Inclusion
- The duration of surgical intervention is between 2 and 4 hours,
- Ability to read, write, understand and communicate in Turkish,
- Voluntary participation in the study,
- Does not require follow-up in intensive care before or after surgery,
- Dementia, alzheimer etc. absence of disease affecting cognitive functions,
- Absence of a disease that may affect thermoregulation due to systemic effects such as chronic obstructive pulmonary disease (COPD), cancer, intracranial benign/malignant tumor, epilepsy, multiple sclerosis, Parkinson's disease, and thyroid-related diseases,
- Absence of drug use that may affect thermoregulation,
- It is not uncomfortable to wear heat socks during application.
Exclusion
- Mental retardation and the presence of any psychiatric disorder,
- Being addicted to alcohol and drugs,
- Dementia, alzheimer etc. have a disease that affects cognitive functions,
- Having drug use that may affect thermoregulation,
- Discomfort from wearing heat socks during application,
- Having any disease that affects tissue perfusion,
- Presence of any peripheral arterial and venous disease,
- The need for intensive care before or after surgery
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06988696
Start Date
November 1 2024
End Date
June 30 2025
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seval Ulubay
Samsun, Atakum/Samsun, Turkey (Türkiye), 55200